Friesian Hydrocephalus
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
A concise guide to the condition’s pattern, detection, management and urgency.
This snapshot is a general guide, not a diagnosis or treatment plan. New, severe or worsening signs require veterinary assessment.
Friesian hydrocephalus is a lethal autosomal recessive developmental disorder associated with a B3GALNT2 variant. Cerebrospinal fluid accumulates within enlarged brain ventricles before birth, expanding the skull and compressing brain tissue. The affected fetus often has a markedly domed head that is too large to pass through the mare's pelvis.
Most cases present as abortion, stillbirth or severe dystocia. If delivered alive, the foal may have an enlarged rounded cranium, abnormal eye position, neurological depression, seizures, inability to stand or nurse and other congenital abnormalities. The oversized head can obstruct the birth canal even when the limbs and body are correctly presented. Prolonged attempts at traction endanger the mare through exhaustion, haemorrhage and uterine or vaginal trauma.
Not every difficult Friesian foaling or large-headed fetus has this mutation. Other malformations, fetal oversize, wrong posture and non-inherited hydrocephalus remain possible. Conversely, an affected conceptus may be lost before a recognisable foal is examined. The disorder is genetic, not caused by the mare's behaviour or an infection acquired during delivery.
Clinically normal carriers have one copy. When two carriers are paired, each pregnancy has a 25% affected risk. There is no treatment capable of reversing the prenatal brain malformation, and live affected foals are not viable. The immediate clinical priority in dystocia is saving the mare through rapid expert delivery. The long-term solution is testing Friesian breeding stock and excluding carrier-to-carrier matings, rather than attempting to identify carriers by appearance or past fertility.
Expansion occurs before birth within a closed skull, destroying normal brain architecture as well as increasing head size. That combination explains both obstructed delivery and profound neurological dysfunction in a liveborn foal. Even if fluid pressure could be diverted after birth, lost cerebral tissue and associated developmental abnormalities would remain.
Late-gestation ultrasound may identify an enlarged fetal skull or dilated ventricles in some cases, but fetal position and access limit sensitivity. During dystocia, vaginal examination determines presentation and detects an oversized head; transrectal ultrasound can help assess fetal viability and uterine position. Forceful traction is stopped when the head cannot enter the pelvis.
After abortion or delivery, skull measurements, imaging and necropsy document hydrocephalus and associated brain compression. A validated DNA test for the Friesian B3GALNT2 variant confirms affected, carrier or clear status from fetal tissue, blood or hair roots. Parentage and sample identity matter when management of an entire family follows the result.
All breeding Friesians are tested before pairing because carriers are clinically indistinguishable from clear horses. A negative result for the known variant does not exclude hydrocephalus from another developmental cause. Previous normal foals do not clear either parent; each conception has an independent genetic outcome.
The mare is monitored for haemorrhage and uterine damage throughout diagnosis of an obstructed fetus.
A hydrocephalic dystocia is an obstetric emergency. The veterinarian rapidly determines whether vaginal delivery is feasible and whether the fetus is alive. Controlled vaginal delivery under anaesthesia, caesarean section or, for a dead fetus in suitable circumstances, skilled fetotomy may be required. Repeated uncontrolled traction is avoided because it cannot compress a severely enlarged skull safely and can destroy the mare's reproductive tract.
The mare receives treatment for shock, haemorrhage, birth-canal injury and pain, followed by immediate retained-placenta monitoring, antimicrobials when contamination warrants them and laminitis surveillance. A live severely affected foal receives brief supportive care while diagnosis is confirmed, then humane euthanasia because the structural brain damage is incompatible with a normal life. Shunting or long-term neurological treatment is not a practical cure for this congenital syndrome.
Future prevention uses DNA results. Carriers are bred only to clear horses; two carriers are never paired. Carrier offspring are healthy but require testing before breeding. Results follow permanent identity and are disclosed for semen, embryos and sales. Fetal or embryo testing may be used in specialist breeding programmes. After an unexplained dystocia or abortion, retaining tissue for testing prevents loss of the information needed to protect the mare in later pregnancies.